The OK means the Food and Drug Administration will likely approve the vaccine, called Pentacel. It would be given in four doses. The advisers also recommended follow-up studies on the vaccine.
The vaccine could eliminate seven of the 23 federally recommended shots children are given through the age of 18 months. Already available in eight other countries, the vaccine was first sold in Canada in 1997.


